Endoprosthesis that can be percutaneously implanted in the patient's body
First Claim
Patent Images
1. An endoprosthesis comprising:
- an elongated hollow structure, the structure being deliverable into a body lumen of a patient for dwelling therein, the structure being expandable and having an initial state of decreased outer diameter during delivery relative to the outer diameter of the structure during dwelling; and
a lining impregnated with a medication for delivery to the patient, the lining being continuous and connected along the structure and expandable therewith, the lining deforming plastically during the expansion of the hollow structure, such that the lining does not crack during expansion.
0 Assignments
0 Petitions
Accused Products
Abstract
An endoprosthesis is provided. In one embodiment the endoprosthesis may include an elongated hollow structure that may be deliverable into a body lumen of a patient for dwelling therein. This structure may be expandable and may have an initial state of decreased outer diameter during delivery relative to the outer diameter of the structure during dwelling. The endoprosthesis may also include a lining impregnated with a medication for delivery to the patient wherein the lining may be continuous and connected along the structure and expandable therewith. It may also be deformable under pressure associated with expansion of the hollow structure, such that the lining does not crack during expansion.
183 Citations
30 Claims
-
1. An endoprosthesis comprising:
-
an elongated hollow structure, the structure being deliverable into a body lumen of a patient for dwelling therein, the structure being expandable and having an initial state of decreased outer diameter during delivery relative to the outer diameter of the structure during dwelling; and
a lining impregnated with a medication for delivery to the patient, the lining being continuous and connected along the structure and expandable therewith, the lining deforming plastically during the expansion of the hollow structure, such that the lining does not crack during expansion. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
a detachable medicating tube associated with the lining.
-
-
6. The endoprosthesis of claim 1 wherein the lining includes an outer layer having pores which widen during expansion, the medication being released upon expansion of the outer layer.
-
7. The endoprosthesis of claim 1 wherein the lining includes an inner layer having pores which widen during expansion, the medication being released upon expansion of the inner layer.
-
8. The endoprosthesis of claim 1 wherein the medication includes a genetic material.
-
9. The endoprosthesis of claim 1 wherein the medication includes an anti-arteriosclerotic.
-
10. The endoprosthesis of claim 1 wherein the medication includes an antithrombotic.
-
11. The endoprosthesis of claim 1 wherein the medication includes a cytostatic.
-
12. The endoprosthesis of claim 1 wherein the medication is dissolved in the lining.
-
13. The endoprosthesis of claim 1 wherein the medication is encapsulated in beads impregnated in the lining.
-
14. The endoprosthesis of claim 1 wherein the lining is biodegradable.
-
15. The endoprosthesis of claim 1 wherein the lining includes pores.
-
16. The endoprosthesis of claim 15 wherein the lining has pores with a diameter no larger than 0.5 μ
- m.
-
17. The endoprosthesis of claim 1 wherein the lining comprises more than one layer.
-
18. The endoprosthesis of claim 17 wherein each of the layers includes a different medication.
-
19. The endoprosthesis of claim 17 wherein the layers biodegrade at different rates.
-
20. The endoprosthesis of claim 17 wherein an inner layer biodegrades more rapidly than an outer layer.
-
21. The endoprosthesis of claim 17 wherein an inner layer is impregnated with a rheological substance and an outer layer is impregnated with a cytostatic.
-
22. The endoprosthesis of claim 1 wherein the lining has a cuff at one end.
-
23. The endoprosthesis of claim 1 further comprising:
at least one medicating tube in fluid communication with the lining.
-
24. The endoprosthesis of claim 23 wherein the at least one medicating tube is releasably coupled to the lining.
-
25. The endoprosthesis of claim 23 wherein the at least one medicating tube comprises apertures of medicating tubes uniformly distributed around the lining.
-
26. The endoprosthesis of claim 23 wherein the at least one medicating tube is adapted to accommodate radioactive liquids.
-
27. The endoprosthesis of claim 1 wherein the lining is made of at least one of the following compounds:
- a polyacrylic or albumin cross-linked with glutaraldehyde.
-
28. The endoprosthesis of claim 1 wherein the lining is permeable to metabolites and oxygen.
-
29. The endoprosthesis of claim 1 wherein the lining has been formed around the structure by placing the structure into a mold and pouring the lining material into the mold.
-
30. The endoprosthesis of claim 1 wherein the lining is sized to engage the structure after the structure has expanded to more than substantially half of its final deployed size.
Specification